[Comment] Thank you to The Lancet Oncology’s reviewers in 2023

Related Posts

• [Corrections] Correction to Lancet Oncology 2023; 24: 855–67

  Han X, Yang NN, Nogueira L, et al. Changes in cancer diagnoses and stage distribution…

• [Corrections] Correction to Lancet Oncology 2023; 24: 1029–41

  Hurvitz SA, Bardia A, Quiroga V, et al. Neoadjuvant palbociclib plus either giredestrant or anastrozole…

• [Comment] Common Sense Oncology: outcomes that matter

  Oncology needs a recalibrated approach that is more patient centred and prioritises equitable cancer care.…